| Alternative approaches to overcome chemoresistance to apoptosis in cancer S Balaji, D Terrero, AK Tiwari, CR Ashby Jr, D Raman Advances in Protein Chemistry and Structural Biology 126, 91-122, 2021 | 18 | 2021 |
| Oncology biosimilars: New developments and future directions RD Bachu, M Abou‐Dahech, S Balaji, SHS Boddu, S Amos, V Singh, ... Cancer Reports 5 (11), e1720, 2022 | 7 | 2022 |
| IND-2, a quinoline derivative, inhibits the proliferation of prostate cancer cells by inducing oxidative stress, apoptosis and inhibiting topoisomerase II S Balaji, R Neupane, S Malla, R Khupse, H Amawi, S Kumari, ... Life 12 (11), 1879, 2022 | 5 | 2022 |
| Antiproliferative Efficacy of N-(3-chloro-4-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine, DW-8, in Colon Cancer Cells Is Mediated by Intrinsic Apoptosis R Neupane, S Malla, MS Abou-Dahech, S Balaji, S Kumari, DK Waiker, ... Molecules 26 (15), 4417, 2021 | 4 | 2021 |
| Insulin Receptor–Expressing T Cells Appear in Individuals at Risk for Type 1 Diabetes and Can Move into the Pancreas in C57BL/6 Transgenic Mice N Nandedkar-Kulkarni, E Esakov, B Gregg, MA Atkinson, DG Rogers, ... The Journal of Immunology 206 (7), 1443-1453, 2021 | 2 | 2021 |
| Development of novel pyrimido-pyrazolo-quinolone derivative, IND-2 as multi-targeted inhibitor for the treatment of prostate cancer S Balaji, R Neupane, C Karthikeyan, JB Ramapuram, AK Tiwari Cancer Research 83 (7_Supplement), 4974-4974, 2023 | | 2023 |
| Betapropiolactone S Balaji, R Neupane, AK Tiwari, SD Ray Elsevier, 2023 | | 2023 |
| Design and development of novel anticancer dimethoxyquinazoline-4-amine analog, DW-8, against colorectal cancer R Neupane, S Malla, MS Abou-Dahech, S Balaji, S Kumari, Y Tang, ... Cancer Research 82 (12_Supplement), 5656-5656, 2022 | | 2022 |
| Dacarbazine N Patel, R Neupane, S Balaji, AK Tiwari, SD Ray Elsevier, 2022 | | 2022 |
